Rothschild Investment LLC’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252 Sell
15
-10
-40% -$140 ﹤0.01% 3413
2026
Q1
$298 Hold
25
– – ﹤0.01% 3232
2025
Q4
$386 Sell
25
-110
-81% -$2.02K ﹤0.01% 2991
2025
Q3
$2.92K Sell
135
-20
-13% -$446 ﹤0.01% 1993
2025
Q2
$3.45K Buy
155
+25
+19% +$556 ﹤0.01% 1696
2025
Q1
$3.09K Buy
130
+85
+189% +$2.01K ﹤0.01% 1659
2024
Q4
$953 Sell
45
-35
-44% -$918 ﹤0.01% 2241
2024
Q3
$2.58K Buy
80
+55
+220% +$1.62K ﹤0.01% 1597
2024
Q2
$595 Buy
25
+15
+150% +$385 ﹤0.01% 1905
2024
Q1
$298 Buy
+10
New +$313 ﹤0.01% 1560

Other funds holding SGRY

Rothschild Investment LLC's SGRY Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Surgery Partners (SGRY) stake by 40% in Q2 2026, selling an estimated $140 and leaving 15 shares worth $252. The position accounts for ﹤0.01% of the portfolio, ranked #3413.

Rothschild Investment LLC first reported a position in SGRY in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.45K in Q2 2025. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Rothschild Investment LLC held 15 shares of Surgery Partners worth $252 as of Q2 2026.
  • Rothschild Investment LLC sold 10 Surgery Partners shares in Q2 2026, an estimated $140.
  • Surgery Partners made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3413 holding.
  • Rothschild Investment LLC first reported a position in Surgery Partners in Q1 2024 and has held it in 10 quarters since.
  • Rothschild Investment LLC's Surgery Partners position peaked at $3.45K in Q2 2025.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.